A new pocket for D4
Crystal structure paves way to dopamine D4 receptor-selective agonists
The early promise of the dopamine D4 receptor as a therapeutic target for psychiatric disorders hasn’t been borne out because of the difficulty of producing sufficiently selective compounds. Last month in Science, a collaboration between UNC Chapel Hill and UCSF united crystallography and in silico drug discovery to find a selective D4 agonist that could spur new cognitive therapies.
The study was led by Bryan Roth, a pharmacology professor at University of North Carolina at